Jan 10, 2025
Alcohol and cancer, GLP-1 trial representativeness, diagnosing
CAD, changing stroke rates in patients with AF, blanking periods
after AF ablation are the topics John Mandrola, MD, covers this
week.
This podcast is intended for healthcare professionals
only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Surgeon General Causes Hoopla Regarding ETOH
Warning
Dry January: Should Doctors Make It
Year-Round?
https://www.medscape.com/viewarticle/dry-january-should-doctors-make-it-year-round-2025a100009t
- Surgeon General Warning
https://www.hhs.gov/about/news/2025/01/03/us-surgeon-general-issues-new-advisory-link-alcohol-cancer-risk.html
- GBD 2016 Collaboration Lancet
https://doi.org/10.1016/S0140-6736(18)31310-2
- RCT Voskobonik and colleagues
https://www.nejm.org/doi/full/10.1056/NEJMoa1817591
- Marcus and colleagues; UCSF
https://pubmed.ncbi.nlm.nih.gov/33516710/
- Review of ETOH AF
https://doi.org/10.1016/j.jacc.2016.08.074
II. GLP-1 Agonists for Obesity –Trial vs Real
World
- Generalizability of Trial Results
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2826335
- HRS Document ICD
http://dx.doi.org/10.1016/j.hrthm.2014.03.041
III. Stress Testing and CAD Severity
- Reynolds and colleagues. Observational ISCHEMIA
Sub-analysis
https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.123.013743
- Foy Meta-analysis
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2655243
- ISCHEMIA
https://www.nejm.org/doi/full/10.1056/NEJMoa1915922
IV. Changing Stroke Rates with AF
- Teppo and colleagues. Finnish Study
https://doi.org/10.1016/j.jacep.2024.10.029
- Quinn and colleagues.
https://www.ahajournals.org/doi/10.1161/circulationaha.116.024057
V. Patients’ Lives Don’t Pause for Blanking
Periods
- Ruzieh and colleagues.
https://doi.org/10.1016/j.ahjo.2024.100497
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean
of Weill Cornell Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net